David Schaefer, MD
Psychiatry · Saint George, UTNPI 1881891224
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $238 of the $349 with a category attached, or 68.1%. 9 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 31.9% of the total.
Across 15 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$111
- Johnson & Johnson$42
- E.r. Squibb & Sons, L.L.C.$40
- Otsuka America Pharmaceutical, Inc.$33
- Alkermes, Inc.$31
- Lundbeck LLC$31
- plus $62 from 3 others
What the payments were for
- Food & beverage$23868%
- Education$11132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Johnson & Johnson | 3 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Alkermes, Inc. | 2 | $31 |
| Lundbeck LLC | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| AbbVie | 1 | $22 |
| Shire North American Group Inc | 1 | $14 |
How this compares
$349 in reported general payments places this provider in the 75th percentile of 231 psychiatry providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 23 | $216,843 |
| Invega SustennaPaliperidone Palmitate | 56 | $194,770 |
| Abilify MaintenaAripiprazole | 40 | $113,274 |
| AustedoDeutetrabenazine | 13 | $100,143 |
| IngrezzaValbenazine Tosylate | 12 | $98,273 |
| VraylarCariprazine Hcl | 44 | $63,020 |
| AristadaAripiprazole Lauroxil | 27 | $52,854 |
| Seroquel XrQuetiapine Fumarate | 26 | $22,294 |
| TrintellixVortioxetine Hydrobromide | 27 | $16,900 |
| VivitrolNaltrexone Microspheres | 11 | $16,895 |
| SecuadoAsenapine | 11 | $16,210 |
| Aripiprazole | 165 | $12,403 |
| Asenapine Maleate | 45 | $9,578 |
| Paliperidone ErPaliperidone | 25 | $8,715 |
| Clozapine | 120 | $7,611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza, Invega Sustenna | $42 | $411,61379 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $33 | $113,27440 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $111 | $100,14313 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $26 | $98,27312 claims |
| Alkermes, Inc.Aristada, Vivitrol | $31 | $69,74938 claims |
| AbbVieVraylar | $22 | $63,02044 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 231 psychiatry providers in Utah.
Other psychiatry in Saint George
- Michael MeasomSlc$2.2M
- Noel GardnerSalt Lake City$512K
- Reid RobisonOrem$133K
- Thomas RaynerProvo$60K
- Trent HolmbergDraper$32K
- Nathan CurrierRiverton$21K
- Oliver McPhersonBountiful$20K
- Frederick ReimherrSalt Lake City$18K
- Lisa FraleighLogan$8K
- Clark JohnsonSalt Lake City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.